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Milk was collected from each of 18 cows (presenting a  even spread of 1st, 2nd and 3rd 29 
lactation): colostrum on the day of calving and subsequent morning milk 1–5 days post 30 
parturition. Days post parturition significantly affected the fatty acid profile of colostrum and 31 
transition milk samples. The colostrum fatty acid profile was distinctly different from that of 32 
mature milk, with significantly higher levels of polyunsaturated and saturated fatty acids. 33 
Parity of the cow had a significant effect on the fatty acid profile of colostrum and transition 34 
milk samples; conjugated linoleic acid was significantly higher in cows entering their 1st35 
lactation than in those in their 3rd lactation, while multiparous cows produced significantly 36 
higher concentrations of C16:0. The changing composition of the fatty acid profile can be 37 
classed into three distinct phases: colostrum (D0), transition milk (D1 and D2 post 38 
parturition) and mature milk (D3 to D5). 39 
______________________________________________________________________ 40 
1. Introduction 41 
 42 
Colostrum is the initial milk secreted by mammals po t parturition, the composition of 43 
which differs significantly from that of mature milk. Colostrum has an evolutionary design 44 
providing an initial source of essential nutrients for the new born mammal. A number of 45 
factors can affect the composition of bovine colostrum, including breed, lactation number, 46 
diet (Zarcula et al., 2010), length of dry period prepartum and time post-partum. In addition, 47 
the biological function of colostrum and its compositi n, changes in the days post parturition 48 
as it transitions from being colostrum to mature milk (Tsioulpas, Grandison, & Lewis, 2007). 49 
The definition of time periods associated with each of these stages varies considerably in the 50 
literature from classification as colostrum immediately after parturition, to also include 51 
between 5 and 7 days post-partum (McGrath, Fox, McSweeney, & Kelly, 2016). As a result 52 
of the differences in macro components of colostrum co pared with mature milk, greater 53 
knowledge of its composition relative to the transition periods would be beneficial to 54 
minimise undesirable mixing of raw milk with colostrum prior to processing. Such 55 
information may avoid encountering processing related issues that have previously been 56 
reported with colostrum (Tsioulpas et al., 2007); furthermore, the segregation of colostrum 57 
from mature milk can also be important in instances where antibiotic dry cow treatments are 58 
used.  59 
Accounting for approximately 0.5% of a cows annual milk production (Scammell, 60 
2001), research on bovine colostrum has focused on its role in the initial development of the 61 
calf. Colostrum has a significant effect on the development of the calf through the provision 62 
of passive immunity (Korhonen, Marnila, & Gill, 200), influencing metabolism, endocrine 63 
systems, and development of the gastrointestinal tract (Blum & Hammon, 2000). It is 64 
essential that the new-born calf receives an adequat  s pply of colostrum in the early stages 65 
of life, as although colostrum is a rich source of immunoglobulins both their concentration 66 
and the permeability of the gut decreases rapidly in the first 24 h post-partum (Weaver, Tyler, 67 
VanMetre, Hostetler, & Barrington, et al., 2000). Indeed Fischer et al. (2018), found that 68 
delaying colostrum feeding within 12 h of life decrases the passive transfer of IgG, and may 69 
delay the colonisation of bacteria in the intestine, creasing the risk of infection to the calf.   70 
Although surplus colostrum was previously thought of as unmarketable (Foley & 71 
Otterby, 1978), in recent years the bioactive components in bovine colostrum have attracted 72 
interest as a potentially beneficial food ingredient for the future (Sacerdote et al., 2013). As 73 
mentioned previously, with levels accounting for 0.5% of cows’ annual milk production, this 74 
quantity does represent a viable stream for further processing into high value products. 75 
Colostrum has been sold in tablet form, in powder form or as colostrum based drinks 76 
(Boland, 2010). Mizelman, Duff, Kontulainen, and Chilibeck (2017) on review of the topic, 77 
highlighted how supplementation of the diet with bovine colostrum appears to improve 78 
immune function and prevent inflammation after exercise. In rodent models, the consumption 79 
of colostrum has been demonstrated to prevent gastrointestinal injury as a result of taking 80 
non-steroidal inflammatory drugs (Playford et al., 1999). Another consideration in the 81 
commercial production of bovine colostrum is that, while the cow produces far in excess of 82 
the amount required by the calf, the availability of c lostrum can be dependent on the type of 83 
lactational system being practised at farm level. Sasonal calving systems, such as that in 84 
Ireland and New Zealand, result in colostrum only being available for a short period at the 85 
beginning of the lactational cycle, whereas a year round calving system would result in a 86 
consistent supply of colostrum. 87 
There is an abundance of information available relative to the changes that occur to 88 
the macro components of colostrum in the first days po t parturition (El-Fattah, Rabo, El-89 
Dieb, & El-Kashef, 2012; Tsioulpas et al., 2007), with in-depth research focusing on the 90 
protein fraction (Senda, Fukuda, Ishii, & Urashima, 2011; Tsioulpas et al., 2007). However, 91 
knowledge of the changes occurring in relation to fa  composition during the different 92 
transition stages is currently limited. The objective of this study was to examine the influence 93 
of days post parturition and parity of cow on the fatty acid (FA) profile of bovine colostrum 94 
in an Irish context. This study provides a robust overview of the changes taking place to 95 
better define the stages of transition, as colostrum evolves into mature milk over the first 5 96 
days of lactation relative to the fatty acid profile.   97 
 98 
2.  Materials and methods 99 
 100 
2.1. Reagents 101 
 102 
Heptane, sodium hydrogen monohydrate and 25% sodium methoxide were purchased 103 
from Sigma Aldrich (Dublin, Ireland). Diethyl ether was purchased from Fisher Scientific 104 
(Dublin, Ireland). The internal standard trinonadecanoin (C19:0 TAG) [part number T-165] 105 
which was used for sample prep and a standard of CLAc9t11 were purchased from Nu Chek-106 
prep, Inc (Elysian, MN, USA). Fatty acid methyl ester (FAME) standard mix containing C4:0 107 
to C24:0 (Part number 35077) was purchased from Thames Restek UK Ltd 108 
(Buckinghamshire, UK).  C19 FAME was purchased from Sigma Aldrich. 109 
 110 
2.2.  Experimental design 111 
 112 
Eighteen Holstein Friesian cows consisting of an even spread of 1st lactation (n = 6), 113 
2nd lactation (n = 6) and 3rd lactation (n = 6) were selected from the spring calving dairy herd 114 
based at the Teagasc Moorepark Dairy Research Farm, er oy Co. Cork, Ireland. Prior to 115 
calving, animals were fed grass silage (40% of DM), straw (30% of DM) and a blended 116 
concentrate (30% of DM) (rolled barley and maize gluten meal at a 60:40 ratio). Animals had 117 
access to feed 24 h per day and fresh clean water. Animals were feed to 100% ULF 118 
requirement plus a 10% refusal, and feeding was adjusted in accordance with month of 119 
gestation. Animals remained on this diet from dry off until one week post calving when 120 
animals were turned out to grazed grass.  121 
In total, 6 milk samples were collected from each cow onsisting of colostrum taken 122 
on the day of calving, and subsequent morning milk 1, 2, 3, 4, and 5 days post parturition. 123 
Each cow was milked into a separate stainless steel churn at milking time to enable sample 124 
collection. Approximately 400 mL of milk was collect d from each cow and immediately 125 
refrigerated at 4 °C. Once aliquoted for respective testing, samples were frozen at –20 °C 126 
prior to analysis. For continuity, all analysis was carried out sequentially once the entire 127 
sample set was collected.    128 
 129 
2.3.  Fat content analysis 130 
 131 
Fat content of the colostrum and milk samples was an lysed using the Röse–Gottlieb 132 
method (IDF, 1996). 133 
 134 
2.4. Fatty acid analysis 135 
 136 
Lipid extraction was performed as per the procedure o tlined by De Jong and Badings 137 
(1990) similarly to that of O'Callaghan et al. (2016, 2019). Briefly, 10 mL of ethanol (98% 138 
purity), and 1 mL of 2.5 M H2SO4 was added to 10 mL of each sample and mixed. This 139 
mixture was extracted three times with 15 mL diethyl ether/heptane (1:1) and each time the 140 
solution was clarified by centrifugation at 1500 × g for 5 min. The collected extracts were 141 
pooled and dried down at 55 °C under N2 gas.  142 
For methyl ester derivatisation of triglycerides (TAG), a volume of 4.8 mL of C19:0 143 
TAG (500 ppm) in heptane was added to ~60 mg of the extracted lipid sample, following this 144 
200 µL of 2 M sodium methoxide solution was added and the sample was mixed vigorously 145 
for about 30 s. Then, 1g of sodium hydrogen sulfate monohydrate (Sigma Aldrich) was added 146 
to the solution and the mixture was again shaken vigorously. After the salt had settled, the 147 
upper layer containing the methyl esters was decantd i o a clean test tube and diluted with 148 
8 mL of heptane. FAMEs were stored at –20 °C prior to gas chromatography analysis in 2 149 
mL amber vials which were capped with PTFE/white silicone septa.  150 
FAME analysis was performed on an Agilent 7890A gas chromatograph system, 151 
equipped with an Agilent 7693 autosampler (Agilent Technologies, Cork, Ireland) and flame 152 
ionisation detector (FID). The column was a Select FAME capillary column (100 m × 250 153 
µm I.D., 0.25 µm phase thickness, part number: CP7420) (Agilent Technologies, Little 154 
Island, Cork, Ireland). The injector was held at 250 °C for the entire run and was operated in 155 
split mode using a split ratio of 1:10. The inlet liner was a split gooseneck liner (Part no: 156 
8004-0164, Agilent Technologies). The column oven was held at 80 °C for 8 min and raised 157 
to 200 °C at 8.5 °C min-1 and held for 55 min. The total runtime was 77.12 min. The FID was 158 
operated at 300 °C. The carrier gas was hydrogen and w s held at a constant flow of 1.0 mL 159 
min-1. Results were processed using OpenLab CDS Chemstation edition software version 160 
Rev.C.01.04 (35) (Agilent Technologies).  161 
All standard mixtures were prepared in heptane and stored at −18 °C until analysis. 162 
The maximum allowable storage time was 6 months. Quantitation of FAMEs was carried out 163 
by establishing calibration curves using the C4:0–C24:0 FAME reference mix and CLA 164 
standard. 5 point curves with concentrations from 10 to 900 ppm were used with a coefficient 165 
of determination (R2) of no less than 0.99 being accepted. The necessary dilutions with 166 
heptane were carried out using the sample prep Workbench (Agilent Technologies). C19 167 
FAME was added as in internal standard (ISTD), to give a final concentration of 200 ppm, 168 
during the dilution step prior to GC-FID analysis. Quantitation of individual FAMEs was 169 
based on their correction factors against the ISTD. 170 
The FAME reference mix was also used as an in-run quality control sample, with the 171 
FAMEs present at 60–180 ppm concentration, to ensure accurate quantitation was being 172 
achieved throughout sample analysis. When setting up a sample batch for GC-FID analysis, 173 
the FAME mix was analysed once every 10 samples in the sequence. Accuracy was 174 
monitored by comparing the measured concentration of this FAME mix against its true 175 
concentration.   176 
 177 
2.5. Statistical analysis 178 
 179 
Statistical analysis was performed using SPSS v24.0 (IBM Statistics Inc., Armonk, 180 
NY). A between- and within-subjects repeated measures ANOVA with post hoc Tukey test 181 
was used to compare the FA content of colostrum and milk samples over the days post 182 
parturition (D0, Day 1, Day 2, Day 3 Day 4 and Day 5) from herds on different number of 183 
lactations (1st, 2nd, and 3rd); p-values < 0.05 were considered significant. The strngth of 184 
statistically significant results are also reported as the partial eta2 effect size (η2) where effect 185 
sizes are small (0.01 ≤ η2 < 0.06), medium (0.06 ≤ η2 < 0.14), and large (η2 ≥ 0.14).  186 
Multivariate analysis of the fatty acid profile was l o performed to examine the 187 
impact of day and parity. A supervised multivariate model was built using PLS-DA. To 188 
validate the model, a permutation test with 2000 repetitions was performed to check that the 189 
model differed from a random model. Also, the R2 and Q2 parameters were obtained to assess 190 
the performance of the model using 10 fold cross validation approach. The variable 191 
importance plot (VIP) shows which variables have a larger influence on the latent variables 192 
of the built model. Each of these tests and generation of subsequent Figures were carried out 193 
using Metaboanalyst (www.metaboanalyst.ca)  (Chong et al., 2018; Xia & Wishart, 2016). 194 
The atherogenicity index (AI) and thrombogenicity index have been calculated as 195 
described by Ulbricht and Southgate (1991). The desaturase index (DI) is calculated as the 196 
[sum   of delta 9  desaturase   products]/[sum   of delta 9-desaturase products+substrates], 197 
(Kay, Roche, Kolver, Thomson, & Baumgard, 2005). Results presented in the text are mean 198 
± standard deviation unless otherwise stated. 199 
 200 
3.  Results and discussion 201 
 202 
Colostrum is a nutrient-dense and bioactive rich feed source for the new born calf. 203 
The bioactive composition of colostrum has resulted in increased interest for its use as a 204 
potentially beneficial food ingredient (Mizelman et al., 2017). While much of the literature to 205 
date has focused on the protein fraction of colostrum and its immune components 206 
(Stelwagen, Carpenter, Haigh, Hodgkinson, & Wheeler, 2009), comparatively limited 207 
information is known about the lipid fraction. The purpose of this study was to examine and 208 
document the fatty acid profile of colostrum and transition milk as affected by days post 209 
parturition and parity of cows.   210 
The overall fat content of colostrum was higher than that of the transition milks, 211 
statistical analysis of within subjects effects demonstrated that days post parturition had a 212 
significant effect on the fat content of milk; however, follow up pairwise comparison test did 213 
not find any significant differences. There was a larger variation in total fat content between 214 
cows in the Day(D) 0 samples (7.17 ± 2.97%) compared with D1(5.24  ± 1.10%), D2 (4.72 ± 215 
1.10%), D3 (5.08 ± 1.28%), D4 (5.34 ± 1.29%) and D5 milks (5.23 % ± 0.84%). Tsioulpas et 216 
al. (2007), on examination of colostrum and milks between day 1 and day 90 of lactation, 217 
reported that that there was no particular trend observed in the fat content, which varied over 218 
the sampling period. McGrath et al. (2016), on review of the topic, discussed how colostrum 219 
fat content is typically, but not always, higher than that of milk, coupled with variation in fat 220 
composition. Fat content of colostrum and milk samples reported herein are similar to those 221 
reported by El-Fattah et al. (2012) for Holstein cows. 222 
Days post parturition was demonstrated to have a significant effect on the majority of 223 
fatty acids measured with the exception of C11:0. C13:0, C20:0, and C21:0 (Table 1) as 224 
determined by the repeated measures ANOVA analysis. PLS-DA demonstrated the evolution 225 
of the fatty acid profile from colostrum through the transition milk stages to mature or regular 226 
milk on Day 5 (Fig. 1A). While the colostrum fatty acid profile appears distinct at each time 227 
point it is evident that  changes are also taking place in the fatty acid profile between Days 1 228 
and 2 post parturition. While Days 3, 4, and 5 profiles contain some subtle differences, these 229 
samples appear to be more similar than the previous day .  The fatty acids contributing most 230 
to the observed separation of the PLS-DA are present d i  Fig. 1B.  231 
Days post parturition had a significant effect on the de novo fatty acid index (C4:0 to 232 
C15:0) (p = 0.028). De novo fatty acids, which are the fatty cids synthesised in the cows 233 
mammary gland from the volatile fatty acids acetate and butyrate, have increasingly been 234 
used as an indicator of rumen function on commercial dairy farms (Woolpert et al., 2017). 235 
Butyric acid (C4:0) increased significantly between D0 and D5 samples. This was attributed 236 
to significant increases between D0 and D1 (p = < 0.001) and D1 and D2 (p = 0.001) after 237 
which the levels stabilised with no significant changes thereafter. Butyric acid or butyrate 238 
supplementation in calves has received much attention in recent years as a result of its 239 
hypothesised ability to enhance calf growth and intestinal development.  240 
 O’Hara et al. (2018) demonstrated that supplementatio  of calves with butyrate in the 241 
form of sodium butyrate changes the abundance of SCFA producing and health-associated 242 
bacteria in the hindgut of milk-fed calves. Górka, Kowalski, Zabielski, and Guilloteau (2018) 243 
and Guilloteau et al. (2009) also discussed the benficial effects of sodium butyrate 244 
supplementation on maturation of gastrointestinal function, while Guilloteau et al. (2009) 245 
highlighted how this may also be applied to other mammal species. From a human 246 
perspective butyric acid has been highlighted as a modulator of gene function (Smith, 247 
Yokoyama, & German, 1998), and may play a role in ca cer prevention (German, 1999). 248 
Caproic acid (C6:0) and octanoic acid (C8:0) signifcantly increased between D0 and D1 (p < 249 
0.001); following this increase there was no significant change in C6:0 between D1 and D5. 250 
The concentration of lauric acid (C12:0) remained steady across D0, D1 and D2 samples after 251 
which it dropped significantly between D2 and D3 (p = 0.021). Myristic acid (C14:0) and 252 
myristoleic acid (C14:1) were highest in colostrum samples (D0) and decreased significantly 253 
until D3 (p = 0.002) after which they remained constant. Days post parturition also had a 254 
significant effect on pentadecanoic acid (C15:0) concentrations which decreased between D1 255 
and D5 (p = 0.007). Palmitic acid (C16:0) the most abundant s turated fatty acid (SFA) in 256 
milk, and palmitoleic acid (C16:1) were highest in colostrum samples and significantly 257 
decreased  between D0 and D4 (p < 0.001). Negative effects associated with SFA 258 
consumption, include increased levels of total and low density lipoprotein (LDL) cholesterol 259 
in blood, which is considered an important risk factor for cardiovascular disease (CVD), with 260 
C12:0, C14:0, and C16:0 attributed to this effect (Ohlsson, 2010). However, the true effects 261 
of lauric acid on cholesterol has been questioned recently as a result of its ability to increase 262 
the levels of beneficial high density lipoprotein (HDL) (Lordan, Tsoupras, Mitra, & 263 
Zabetakis, 2018). Nevertheless, studies have consiste tly demonstrated that there is no clear 264 
evidence that dairy food consumption is consistently associated with a higher risk of CVD 265 
(German et al., 2009; Guo et al., 2017; Lordan et al., 2018). Heptadecanoic acid (C17:0) 266 
significantly increased between D0 and D3 post-partum (p = 0.003) after which it remained 267 
stable. Stearic acid (C18:0) was significantly affected by time post-partum and increased 268 
between D0 and D5 (p < 0.001); however, there was no significant difference between D4 269 
and D5. The supplementation of lactating cows with C16:0 and C18:0 has been carried out in 270 
the past with a variety of observed benefits. Both fa ty acids have specific roles and functions 271 
in metabolism including provision of energy (Loften t al., 2014). However, from a calf 272 
perspective, Azad-Shahraki, Khani, Ahmadi, Ariana, and Beiranvand (2019) demonstrated 273 
that pre-ruminant calves would not benefit from palmitic acid inclusion in their starter diet. 274 
Oleic acid (C18:1n9c) is one of the most abundant unsaturated fatty acids in milk. The 275 
concentration of oleic acid was lowest in colostrum samples which significantly increased in 276 
concentrations until D3 (p < 0.001). Okada, Goto, Furukawa, Ikuta, and Yasuda (2009) 277 
investigated the impact of supplementing milk replacer and prevalence of white scour which 278 
can cause significant economic losses at farm level. The authors concluded that increases in 279 
saturated long chain fatty acids in milk were closey r lated to the onset of white scour in 280 
calves potentially as a result of poor absorption rates. 281 
Linoleic acid (C18:2n6c) is the most abundant Ω 6 fatty acid in milk and was 282 
significantly higher in colostrum but dropped significantly between D0 and D1, after which it 283 
remained constant (p = 0.004). α-Linolenic acid (C18:3n3), the most abundant Ω 3 fatty acid 284 
in milk, was highest on D0 and D1 samples, after which its concentrations dropped 285 
significantly until D3 and remained constant until D5. Both linoleic and linolenic acid are 286 
classed as essential fatty acids, which act as substrate  for fatty acids important for neural 287 
development and production of hormones, such as 20:5n3, 22:6n-3. 18:3n6, 20:3n6, 20:4n6 288 
(Klein, 2002). As such the aforementioned fatty acids are important for both calf and human 289 
nutrition. Results have demonstrated that supplementatio  of calf starter with C18:2 and 290 
C18:3n3 had a beneficial effect on average daily weight gain and feed efficiency (Hill, 291 
Aldrich, Schlotterbeck, & Bateman, 2007; Hill, Bateman, Aldrich, & Schlotterbeck, 2009). 292 
Both Ω3 and Ω6 fatty acids are precursors to signalling molecules with opposing effects that 293 
modulate the membrane microdomain composition, receptor signalling and gene expression 294 
(Schmitz & Ecker, 2008). Garcia et al. (2015) noted that the balance of these fatty acids is 295 
important, while linoleic acid consumption could help the calf in terms of inflammatory 296 
response when exposed to environmental pathogens, srving as a precursor to pro-297 
inflammatory mediators such as, cytokines and eicosan ids (Calder, 2006). Thus, the anti-298 
inflammatory properties of linolenic acid could also aid in calf inflammatory conditions, 299 
known to impair calf health. CLA c9t11 was lowest in colostrum samples and significantly 300 
increased up to 2 days post-partum (p < 0.001), after which it remained constant.  CLA c9t11 301 
is produced in the rumen as a product of the biohydrogenation of dietary linoleic acid to 302 
stearic acid by rumen microorganisms (Dhiman, Seung-Lee, & Ure, 2005). Previous studies 303 
have demonstrated that animal diet has a significant impact on the content of CLAc9t11 in 304 
milk.  Milk derived from pasture fed cows, for example, have been demonstrated to have 305 
significantly higher content of CLA than that from cows on a total mixed ration diet; this has 306 
been linked to high levels of α-linolenic acid content in fresh forage that is subsequently 307 
converted to CLA (O'Callaghan et al., 2016). However, accenic acid can also be converted 308 
to CLA c9t11 by the action of delta9-desaturase in the mammary gland (Griinari et al., 2000). 309 
In recent years, CLA has received much attention as a result of its interesting biological 310 
functions and apparent benefits to human health as demonstrated in human and animal 311 
models. Such effects include reduction of carcinogeesis, atherosclerosis, inflammation, 312 
obesity, and  diabetes (Yang et al., 2015). 313 
The number of days post parturition also had a significa t effect on a variety of fatty 314 
acid indices derived from the milk fatty acid profiles, as shown in Table 2. In ruminants a key 315 
enzyme influencing the milk fatty acid profile is stearoyl-CoA desaturase 1, this enzyme is 316 
responsible for the conversion of saturated fatty acids with 10–18 carbon atoms into their 317 
monounsaturated fatty acid (MUFA) counterparts and plays a significant role in the synthesis 318 
of CLA in the mammary gland (Kgwatalala, Ibeagha-Awemu, Mustafa, & Zhao, 2009). The 319 
activity of this enzyme is classed as the desaturation index whereby increased activity results 320 
in higher levels of desirable MUFAs with concomitant reduction in SFA concentrations (Reh 321 
et al., 2004). The desaturase index values in the present study were positively correlated with 322 
concentrations of MUFAs (p < 0.001, r = 0.979) and CLA (p = 0.001, r = 0.969) and 323 
significantly negatively correlated with SFA content (p < 0.001, r = –0.979). Days post 324 
parturition had a significant effect on the desaturse index (p < 0.001), which increased 325 
significantly from D0 to D3 post-partum and remained stable thereafter.  Such results appear 326 
to indicate a shift in the enzyme activity of the ma mary gland after D0 (colostrum) resulting 327 
in production of more MUFAs. Both the thrombogenicity index (TI) and atherogenicity index 328 
(AI) were highest in colostrum samples and decreased significantly (p ≤ 0.001) in days post-329 
partum and were lowest at D5. Theses higher values for AI would be resultant of higher 330 
levels of SFAs in the colostrum samples than in the latt r samples including C14:0 and 331 
C16:0. While it was not possible due to logistics to examine the fatty acid profile of these 332 
milks in mid lactation, previous studies from the same farm using seasonal calving systems 333 
have also demonstrated that the fatty acid profile  milks from cows on pasture or total 334 
mixed ration diets continues to evolve throughout lac ation (O'Callaghan et al., 2016).  335 
Contarini et al. (2014) also demonstrated that the fatty acid composition of milks after 5 days 336 
post parturition and 5 months were significantly different.  337 
The lactation number of the cows was also demonstrated to have a significant effect 338 
on some of the fatty acids measured including C14:1, C15:0, C16:0, C18:0, C18:2n6t, 339 
C18:3n3 C20:0, CLA, and C21:0 (Table 1) as determined by the repeated measures ANOVA. 340 
Partial least square discriminant analysis (PLS-DA) demonstrates the differences of the fatty 341 
acid profile between cows in their first (1), second (2), and third (3) lactation (Fig. 2A). It can 342 
be noted that the fatty acid profiles of milk from 1st lactation and 3rd lactation cows are 343 
different from each other, while that from 2nd lactation cows appears to fall between both 344 
groups.  345 
The fatty acids contributing to the observed separation of the PLS-DA are presented 346 
in Fig. 2B, with the major compounds being CLA, C18:3n3, C15:0, C21:0, C17:0, and 347 
C16:0. The current understanding of the mechanisms for these changes in fatty acids is 348 
limited. One potential hypothesis could be that changes in the colostrum and milk fatty acid 349 
profiles are dependent upon the composition and functio ality of the rumen microbiome, 350 
which in itself is linked to the cow based factors including the number of lactations. 351 
Buitenhuis et al. (2019) demonstrated that the rumen icrobiome has a pronounced impact 352 
on the content of odd chain fatty acids and polyunsaturated fatty acids, including C15:0, 353 
C17:0, C18:2n6, C18:3n3, and CLA. Each of these fatty acids originates through 354 
biohydrogenation of feed derived C18 fatty acid by rumen microorganisms or from odd chain 355 
fatty acids that are synthesised by rumen microbes (Vlaeminck, Fievez, Cabrita, Fonseca, & 356 
Dewhurst, 2006). Interestingly, Kumar, Indugu, Vecchiarelli, and Pitta (2015), also 357 
demonstrated that the bacterial community was different between primiparous and 358 
multiparous cows, indicating that the microbiome continues to evolve as the cow progresses 359 
from first to multiple lactations thereafter. Other considerations include nutrient/feed uptake 360 
relative to the cow’s size, which is normally smaller during the first lactation cycle coupled 361 
with immaturity of the mammary gland, both of which may influence fatty acid synthesis. 362 
These results are similar to those reported by Contarini et al. (2014) who concluded that 363 
differences in the fatty acid composition observed b tween the multiparous and primiparous 364 
colostrum samples could be linked to the physiological responses to increased energy 365 
requirements due to the onset of lactation between you ger and older cows.  366 
In summary, colostrum is a nutritionally dense materi l with polyunsaturated, Ω3 and 367 
Ω6 fatty acids, and other components which are beneficial or development. In the 368 
subsequent days post-partum the concentrations of these fatty acids are depleted with 369 
concomitant increases in CLA and other fatty acids beneficial to health. While consumption 370 
of products with increased concentrations of Ω3 fatty acids would be beneficial to health, the 371 
high levels of Ω6 and palmitic acid, however, may be undesirable, considering the excessive 372 
levels of Ω6 already present in the current western diet, coupled with the cholesterol-raising 373 
effects of C16:0. In this regard, from a nutritional perspective the fat profile of milk from day 374 
3 post parturition onwards could be better for human consumption with decreased 375 
concentrations of C16:0, Ω6 fatty acids and concomitant lower indices for AI and TI, coupled 376 
with increased concentrations of unsaturated fatty acids, CLA, C18:0 and C18:1n9c.  Such 377 
differences in the fatty acid profile of colostrum in the days post parturition will be an 378 
important future consideration should the material need to be processed and stabilised for 379 
human consumption.  380 
To date the majority of beneficial factors in colostrum have been associated with the 381 
protein fraction. Nevertheless, it remains to be seen what valorisation strategies could be 382 
applied to the fat portion of colostrum to allow its conversion into attractive products that are 383 
beneficial to the consumer. Therefore, future work on processing characteristics, rheological 384 
and sensory properties of products derived from the fat fraction of colostrum is warranted. 385 
Concentrated fat streams such as cream and anhydrous milk fat would offer potential 386 
mechanisms for the purification of the fat, for subequent incorporation into formulated 387 
products. However, as the results highlight changes occurring in the fatty acid profile may 388 
have a significant effect on the processing characte istics, functionality and nutritional 389 
properties of the products that should be considered when choosing best use strategies for 390 
colostrum and transitionary milk post parturition.   391 
 392 
4. Conclusion 393 
 394 
Our study has demonstrated the impact of days post parturition on the fatty acid 395 
profile of colostrum and transition milk. Days post parturition has a significant effect on the 396 
fatty acid profile; that of colostrum is distinctly different from that of milk produced in 397 
subsequent days, with significantly higher levels of polyunsaturated fatty acids and palmitic 398 
acid. Parity of the cow also has a significant effect on the fatty acid profile of colostrum and 399 
milk samples, with CLA being one of the major compounds impacted, with significantly 400 
higher levels in cows entering their 1st compared with those in their 3rd lactation cycle. 401 
Multiparous cows (lactation number 2 and 3) produce significantly higher concentrations of 402 
C16:0 than primiparous cows. It is clear that the canging composition of the fatty acid 403 
profile can be classed into three distinct phases a it evolves, including colostrum (D0), 404 
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Figure legends 
 
Fig. 1. Panel A, partial least square discriminant analysis (PLS-DA) depicting the changes 
occurring as milk transition from colostrum to milk over five days post parturition [0, 
colostrum (red); 1–5, days 1–5  post parturition (green, blue, light blue, violet, yellow, 
respectively)] (R2, 0.79; Q2, 0.75). Panel B,  variable importance plot highligt ng the fatty 
acids most responsible for observed separations in PLS-DA; the coloured boxes on the right 
indicate the relative concentrations of the corresponding fatty acid in each group under study. 
Panels C–N, fatty acids changing significantly over time (C18:0, C14:0, C16:1, C16:0, 
C20:3n6, C6:0, C4:0, C14:1, C20:2, C23:0, C181n9c and C17:0, respectively; different 
letters denote significant differences. 
 
Fig. 2. Panel A, partial least square discriminant analysis (PLS-DA) depicting the impact of 
parity [i.e., 1st, 2nd and 3rd lactation cows, denoted 1 (red), 2 (green) and 3 (blue), 
respectively) on the fatty acid composition of colostrum and transition milk (R2, 0.52; Q2, 
0.41). Panel B, variable importance plot highlighting the fatty acids most responsible for 
observed separations in PLS-DA based on parity; the coloured boxes on the right indicate the 




Fatty acid content of colostrum and milk samples up to 5 days post parturition from Spring calving cows. a 
Fatty acid Colostrum Days post parturition  p-Value   
 Day1 Day 2 Day 3 Day 4 Day 5  Day η2  Day*Parity η2  Parity η2 
C4:0 3.01 ± 0.79 4.25 ± 0.61 5.05 ± 0.72 5.3 ± 0.63 5.47 ± 0.72 5.64 ± 0.91  <0.001 0.767  0.660 0.093  0.095 0.269 
C6:0 1.42 ± 0.26 2.06 ± 0.32 2.25 ± 0.32 2.19 ± 0.4 2.21 ± 0.49 2.25 ± 0.54  <0.001 0.652  0.861 0.041  0.756 0.037 
C8:0 0.75 ± 0.15 1.01 ± 0.19 1.09 ± 0.21 1.02 ± 0.24 1.02 ± 0.29 1.03 ± 0.32  <0.001 0.467  0.875 0.039  0.734 0.040 
C10:0 1.67 ± 0.47 2.08 ± 0.51 2.12 ± 0.54 1.88 ± 0.53 1.84 ± 0.61 1.86 ± 0.66  0.003 0.309  0.779 0.590  0.488 0.910 
C11:0 0.08 ± 0.08 0.08 ± 0.12 0.06 ± 0.01 0.05 ± 0.01 0.05 ± 0.02 0.04 ± 0.03  0.251 0.088  0.147 0.203  0.917 0.011 
C12:0 2.83 ± 0.86 2.65 ± 0.59 2.6 ± 0.63 2.3 ± 0.6 2.21 ± 0.67 2.21 ± 0.74  0.001 0.376  0.219 0.170  0.392 0.118 
C13:0 0.06 ± 0.02 0.08 ± 0.08 0.06 ± 0.01 0.05 ± 0.01 0.05 ± 0.02 0.05 ± 0.02  0.108 0.159  0.399 0.117  0.366 0.125 
C14:0 13.65 ± 3.49 10.32 ± 1.57 9.45 ± 1.6 8.57 ± 1.53 8.23 ± 1.62 8.26 ± 1.79  <0.001 0.752  0.191 0.188  0.088 0.277 
C14:1 0.96 ± 0.41 0.61 ± 0.13 0.51 ± 0.1 0.42 ± 0.13 0.42 ± 0.1 0.42 ± 0.12  <0.001 0.625  0.145 0.218  0.001 0.633 
C15:0 0.97 ± 0.15 0.95 ± 0.17 0.89 ± 0.16 0.85 ± 0.16 0.82 ± 0.15 0.85 ± 0.17  0.002 0.359  0.730 0.084  0.041 0.347 
C16:0 40.36 ± 5.3 34.61 ± 3.33 31.21 ± 2.91 29.2 ± 2.05 28.26 ± 1.99 28.46 ± 2.22  0.001 0.933  0.000 0.527  0.008 0.472 
C16:1 2.67 ± 0.86 2.11 ± 0.33 1.97 ± 0.36 1.92 ± 0.4 1.81 ± 0.45 1.79 ± 0.54  <0.001 0.510  0.017 0.372  0.416 0.110 
C17:0 0.79 ± 0.2 0.9 ± 0.11 0.91 ± 0.1 0.95 ± 0.11 0.94 ± 0.14 0.94 ± 0.13  <0.001 0.474  0.009 0.382  0.097 0.267 
C18:0 8.02 ± 2.34 10.8 ± 1.27 12.51 ± 1.32 14.38 ± 1.05 15.38 ± 1.44 15.83 ± 2.63  <0.001 0.848  0.146 0.195  0.007 0.481 
C18:1 n9c 20.92 ± 5.79 23.86 ± 4.19 25.77 ± 4.14 27.45 ± 4.11 27.79 ± 4.49 26.41 ± 7.35  <0.001 0.713  0.005 0.403  0.405 0.113 
C18:2 n6c 1.95 ± 0.47 1.58 ± 0.27 1.5 ± 0.24 1.53 ± 0.25 1.51 ± 0.23 1.53 ± 0.24  <0.001 0.535  0.586 0.079  0.490 0.091 
C18:2 n6t 0.37 ± 0.29 0.14 ± 0.09 0.21 ± 0.23 0.21 ± 0.21 0.31 ± 0.36 0.73 ± 0.55  0.001 0.331  0.168 0.180  0.043 0.342 
C20:0 0.14 ± 0.04 0.14 ± 0.04 0.15 ± 0.03 0.15 ± 0.02 0.16 ± 0.03 0.17 ± 0.04  0.136 0.129  0.604 0.080  0.001 0.588 
C18:3 n3 0.79 ± 0.21 0.79 ± 0.18 0.76 ± 0.15 0.73 ± 0.14 0.71 ± 0.13 0.7 ± 0.12  0.004 0.303  0.132 0.01   0.010 0.456 
CLA c9t11 0.5 ± 0.22 0.61 ± 0.21 0.67 ± 0.19 0.68 ± 0.18 0.68 ± 0.16 0.65 ± 0.16  <0.001 0.652  0.152 0.003  0.003 0.531 
C21:0 0.02 ± 0.01 0.02 ± 0.01 0.02 ± 0.01 0.02 ± 0 0.02 ± 0 0.02 ± 0.01  0.126 0.120  0.103 0.004  0.004 0.522 
C20:2 0.02 ± 0.01 0.02 ± 0.01 0.01 ± 0 0.01 ± 0 0.01 ± 0 0.01 ± 0.01  <0.001 0.407  0.342 0.365  0.365 0.126 
C20:3n6 0.25 ± 0.06 0.14 ± 0.07 0.09 ± 0.02 0.01 ± 0.03 0.01 ± 0.03 0.06 ± 0.02  <0.001 0.837  0.105 0.711  0.711 0.044 
C23:0 0.28 ± 0.08 0.2 ± 0.08 0.16 ± 0.03 0.11 ± 0.03 0.1 ± 0.02 0.1 ± 0.03  <0.001 0.764  0.171 0.052  0.052 0.325 
a Values are the mean ± standard deviation (g 100 g-1 total fatty acids); in total, 108 samples were collected and analysed, n = 6 for each lactation 
number on each day of collection post partum;  η2, partial eta2 effect size where effect sizes are small (0.01 ≤ η2 < 0.06), medium (0.06 ≤ η2 < 0.14), 
and large (η2 ≥ 0.14).  
Table 2 
Fatty acid indices of colostrum and milk samples up to 5 days post parturition from Spring calving cows. a 
Fatty acid 
 
Colostrum Days post parturition  p-Value   
 Day1 Day 2 Day 3 Day 4 Day 5 Day η2  Day*Parity η2  Parity η2 
Saturated 74.05 ± 7.84 70.14 ± 4.67 68.5 ± 4.84 67.03 ± 4.66 66.75 ± 4.94 67.7 ± 7.63  <0.001 0.443  0.093 0.231  0.347 0.132 
Unsaturated 28.4 ± 6.36 29.84 ± 4.66 31.48 ± 4.84 32.96 ± 4.66 33.23 ± 4.94 32.29 ± 7.63  <0.001 0.486  0.072 0.259  0.476 0.094 
MUFA 24.54 ± 5.74 26.58 ± 4.29 28.25 ± 4.42 29.79 ± 4.51 30.01 ± 4.93 28.62 ± 7.78  <0.001 0.561  0.033 0.305  0.511 0.086 
PUFA 3.88 ± 0.69 3.28 ± 0.54 3.25 ± 0.56 3.18 ± 0.58 3.23 ± 0.57 3.68 ± 0.52  <0.001 0.329  0.576 0.096  0.043 0.342 
Omega 3 0.79 ± 0.21 0.79 ± 0.18 0.76 ± 0.15 0.73 ± 0.14 0.71 ± 0.13 0.7 ± 0.12  0.004 0.303  0.357 0.132  0.010 0.456 
Omega 6 2.57 ± 0.46 1.86 ± 0.31 1.8 ± 0.33 1.75 ± 0.39 1.83 ± 0.41 2.32 ± 0.51  <0.001 0.453  0.352 0.132  0.937 0.009 
Omega 9 20.92 ± 5.79 23.86 ± 4.19 25.77 ± 4.14 27.45 ± .11 27.79 ± 4.49 26.41 ± 7.35  <0.001 0.713  0.005 0.403  0.405 0.113 
n3/n6 0.31 ± 0.08 0.43 ± 0.1 0.43 ± 0.08 0.43 ± 0.08 0.4 ± 0.09 0.32 ± 0.1  <0.001 0.482  0.195 0.158  0.061 0.311 
De novo (C4–C15) 25.4 ± 5.48 24.1 ± 3.24 24.05 ± 3.11 22.63 ± 3.46 22.31 ± 4.25 22.61 ± 4.85  0.028 0.218  0.341 0.136  0.438 0.104 
LA/ALA 2.56 ± 0.69 2.1 ± 0.57 2.02 ± 0.41 2.13 ± 0.38 2.16 ± 0.36 2.23 ± 0.38  <0.001 0.538  0.031 0.301  0.231 0.177 
Atherogenicity index 3.7 ± 1.06 2.8 ± 0.72 2.43 ± 0.68 2.12 ± 0.6 2.03 ± 0.56 2.03 ± 0.58  <0.001 0.844  0.003 0.426  0.313 0.144 
Thrombogenicity index 4.01 ± 0.96 3.37 ± 0.68 3.1 ± 0.68 2.91 ± 0.59 2.89 ± 0.56 2.94 ± 0.64  <0.001 0.768  0.001 0.780  0.339 0.134 
Desaturase index 0.28 ± 0.06 0.32 ± 0.05 0.35 ± 0.05 0.36 ± 0.05 0.37 ± 0.05 0.36 ± 0.05  <0.001 0.829  0.001 0.459  0.363 0.126 
 
a Values are the mean ± standard deviation (g 100 g-1 total fatty acid); in total 108 samples were collected and analysed, n = 6 for each lactation 
number on each day of collection parturition. η2, partial eta2 effect size where effect sizes are small (0.01 ≤ η2 < 0.06), medium (0.06 ≤ η2 < 0.14), and 
large (η2 ≥ 0.14). Definitions are: saturated, ∑(C4:0, C6:0, C8:0, C10:0, C11:0, C12:0, C13:0, C14:0, C15:0, C16:0, C17:0, C18:0, C20:0, C23:0); 
unsaturated, ∑(C14:1, C16:1, C18:1n9c, C18:2n6c, C18:2n6t, C18:3n3, CLA c9t11, C20:3n6); MUFA, ∑(C14:1, C16:1, C18:1n9c); PUFA,  






















Figure 2 6 
